ONXX Onyx Pharmaceuticals, Inc. (MM)

Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference 2004 RICHMOND, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it will present at the BIO CEO & Investor Conference 2004 in New York City on Tuesday, February 24, at 2:30 p.m. Eastern Time. Interested parties may access a live webcast of the presentation at: http://www.firstcallevents.com/service/ajwz398915654gf12.html . It is recommended that listeners log on 15 minutes early in order toregister and download any necessary software. If you are unable to participate during the live webcast, a recorded replay of the presentation will be available shortly after the presentation is completed through March 24. Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its partners, the company is developing small molecule drugs, including BAY 43-9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's web site at http://www.onyx-pharm.com/. DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Julianna Wood, +1-510-262-8757, for Onyx Pharmaceuticals Web site: http://www.onyx-pharm.com/

Copyright